6XT Stock Overview
Engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 6XT from our risk checks.
Asahi Intecc Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥15.70 |
| 52 Week High | JP¥19.00 |
| 52 Week Low | JP¥12.10 |
| Beta | 0.62 |
| 11 Month Change | -4.27% |
| 3 Month Change | 26.61% |
| 1 Year Change | -3.09% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -29.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6XT | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -1.3% | 12.4% | 3.1% |
| 1Y | -3.1% | 9.5% | 13.3% |
Return vs Industry: 6XT underperformed the German Medical Equipment industry which returned 9.1% over the past year.
Return vs Market: 6XT underperformed the German Market which returned 13.5% over the past year.
Price Volatility
| 6XT volatility | |
|---|---|
| 6XT Average Weekly Movement | 5.5% |
| Medical Equipment Industry Average Movement | 5.1% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6XT has not had significant price volatility in the past 3 months.
Volatility Over Time: 6XT's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 10,187 | Kenji Miyata | www.asahi-intecc.co.jp |
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally. It operates through Medical Business and Device Business segments. The company provides percutaneous transluminal coronary angioplasty (PTCA) guide wires, PTCA guiding catheters, PTCA balloon catheters, and penetration catheters for cardiology; peripheral guide wires, IVR guide wires, micro catheters, and cerebrovascular system guide wires for peripheral vascular, abdominal vascular, and cerebrovascular systems; and guide wires and catheters for angiography.
Asahi Intecc Co., Ltd. Fundamentals Summary
| 6XT fundamental statistics | |
|---|---|
| Market cap | €4.28b |
| Earnings (TTM) | €98.78m |
| Revenue (TTM) | €672.03m |
43.3x
P/E Ratio6.4x
P/S RatioIs 6XT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6XT income statement (TTM) | |
|---|---|
| Revenue | JP¥107.55b |
| Cost of Revenue | JP¥38.49b |
| Gross Profit | JP¥69.05b |
| Other Expenses | JP¥53.25b |
| Earnings | JP¥15.81b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 14, 2024
| Earnings per share (EPS) | 58.20 |
| Gross Margin | 64.21% |
| Net Profit Margin | 14.70% |
| Debt/Equity Ratio | 4.4% |
How did 6XT perform over the long term?
See historical performance and comparison